News

Delcath’s proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic

Zometa, an intravenous bisphosphonate, is indicated for the prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumor-induced hypercalcemia) in patients with

Fraunhofer said that the purpose of the Phase 1 study is to determine safety of the new vaccine along with appropriate dosage levels. In the trial, the new

The single-arm pivotal trial assessed efficacy and safety of single-agent brentuximab vedotin in relapsed or refractory, post-autologous stem cell transplant (ASCT) Hodgkin lymphoma patients. Brentuximab vedotin is an

rFVIIIFc is a fully-recombinant clotting factor developed using Biogen Idec‘s novel and proprietary monomeric Fc fusion technology. The technology makes use of a natural mechanism that recycles rFVIIIFc

O2h is a discovery services company co-located in Cambridge, UK and Ahmedabad, India. The Indian operations provide chemistry expertise while UK office provides project management support. Phytopharm CEO

The ODD covers both open and closed moderate to severe traumatic brain injury and gives NeuroVive Pharma market exclusivity for NeuroSTAT in the US for seven years from

Since 2007, Ingram has been a general partner of Hatteras Venture Partners, a venture capital firm that invests in early stage life science companies in the southeast US.

The study measured improvements in patients with predominantly negative symptoms of schizophrenia who received RG1678 in combination with second-generation antipsychotics. Genentech said that RG1678 was generally well tolerated